首页> 外文期刊>Nuclear Instruments & Methods in Physics Research. Section A, Accelerators, Spectrometers, Detectors and Associated Equipment >Electrical impedance scanning as a new imaging modality in breast cancer detection―a short review of clinical value on breast application, limitations and perspectives
【24h】

Electrical impedance scanning as a new imaging modality in breast cancer detection―a short review of clinical value on breast application, limitations and perspectives

机译:电阻抗扫描作为乳腺癌检测中的一种新的影像学方法-对乳腺癌应用,局限性和观点的临床价值的简要回顾

获取原文
获取原文并翻译 | 示例
           

摘要

Objective. Cancer cells exhibit altered local dielectric properties compared to normal cells, measurable as different electrical conductance and capacitance using electrical impedance scanning (EIS). Therefore, active biocompatible current is applied to the patient for calculation of both parameters taking into account frequency, voltage and current flow. Subjects and methods. 240 women with 280 sonographically and/or mammographically suspicious findings were examined using EIS. All lesions were histologically proven. A lesion was scored as positive, when a focal increased conductance and/or capacitance was measurable using EIS. The lesion was visible as a bright area in a 256 grey-scale computer output. Due to system limitations patients having a pacemaker or pregnant had to be excluded from the study. Results. 91/113 malignant and 108/167 benign lesions were correctly identified using EIS (80.5% sensitivity, 64.7% specificity). NPV and PPV of 83.1% and 60.7% were observed, respectively. Accuracy was 0.73. A wide range of factors can induce false positive results, although by an experienced observer a number of these findings can be detected such as scars, skin alterations, contact artefacts, air bubbles and naevi, hairs and interfering bone. Based upon visibility on ultrasound (194 lesions visible, 86 not visible) significant differences in the detection rate occurred. Histology-dependent detectability rate varied significantly with lowest rate in CIS-cases (50%). Specificity values varied histology-depending, too; probably depending on the rate of proliferation between 75% (inflammatory lesions) and papillomata (50%). Best detectability was observed in malignant lesions with a size between 20 and 30mm. Further possible applications will be discussed regarding the currently available literature (lymph nodes, salivary glands, mathematical and animal based models). Conclusion. EIS appears to be a promising new additional technology providing a rather high sensitivity for the verification of suspicious breast lesions. Further investigations on histomorphological characteristics of false negative as well as false positive lesions are essential to gain further knowledge about the bioelectricity of breast lesions. Currently high false positive rate and observer-dependence limit clinical usage.
机译:目的。与正常细胞相比,癌细胞表现出改变的局部介电特性,使用电阻抗扫描(EIS)可测量为不同的电导率和电容。因此,考虑到频率,电压和电流,将活性生物相容性电流施加至患者以计算两个参数。主题和方法。使用EIS检查了240位超声检查和/或乳房X线检查可疑的女性。所有病变均经组织学证实。当使用EIS可以测量到局灶性增加的电导和/或电容时,将病变评分为阳性。在256灰度计算机输出中,病变可见为亮区。由于系统限制,必须将具有起搏器或孕妇的患者排除在研究范围之外。结果。使用EIS正确鉴定出91/113恶性和108/167良性病变(敏感性为80.5%,特异性为64.7%)。观察到的NPV和PPV分别为83.1%和60.7%。准确度为0.73。尽管经验丰富的观察者可以发现许多这样的发现,例如疤痕,皮肤改变,接触伪像,气泡和指甲,毛发和干扰骨,但是各种各样的因素都可能导致假阳性结果。根据超声的可见性(可见194个病变,不可见86个病变),检出率发生了显着差异。在CIS病例中,组织学依赖性检出率最低(50%),且差异显着。特异性值也取决于组织学。可能取决于75%(炎症性病变)和乳头状瘤(50%)之间的增殖率。在大小为20至30mm的恶性病变中观察到最佳的可检测性。关于当前可用的文献(淋巴结,唾液腺,基于数学和动物的模型),将讨论其他可能的应用。结论。 EIS似乎是一项很有前途的新技术,可为可疑乳腺病变的验证提供相当高的灵敏度。假阴性和假阳性病变的组织形态学特征的进一步研究对于进一步了解乳腺病变的生物电至关重要。当前高假阳性率和观察者依赖性限制了临床使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号